DRUG · Mapped RxNorm record
Trastuzumab
Normalized identity: trastuzumab View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "
NCT02530424
Study summary
ClinicalTrials.gov"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Pertuzumab
Normalized identity: pertuzumab View linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Palbociclib
Normalized identity: palbociclib View linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Fulvestrant
Normalized identity: fulvestrant View linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Breast Neoplasmsunresolved
Interventions
TrastuzumabDRUG · verified · RxNorm: trastuzumab
PertuzumabDRUG · verified · RxNorm: pertuzumab
PalbociclibDRUG · verified · RxNorm: palbociclib
FulvestrantDRUG · verified · RxNorm: fulvestrant
Sponsors & collaborators
Fondazione Michelangelolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02530424 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.